[EN] EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS<br/>[FR] INHIBITEURS DU RECEPTEUR EP4 DESTINES AU TRAITEMENT DE LA POLYARTHRITE RHUMATOIDE
申请人:PFIZER PHARMA
公开号:WO2002032422A2
公开(公告)日:2002-04-25
The invention features a method of treating rheumatoid arthritis in a mammal comprising administering an agent that inhibits prostaglandin EP4 receptor (EP4) activity. Also featured is a method of identifying agents that selectively inhibit EP4 activity in vivo.